핵의학

본문글자크기
  • 2021년 08월호
    [Nucl Med Commun.] Prognostic value of pretreatment F-18 fluorodeoxyglucose PET/CT in colorectal cancer with unresectable metastasis

    가톨릭대 / 최은경, 오진경*

  • 출처
    Nucl Med Commun.
  • 등재일
    2021 Jun 1
  • 저널이슈번호
    42(6):639-645. doi: 10.1097/MNM.0000000000001384.
  • 내용

    바로가기  >

    Abstract
    Purpose: The aim of the study was to assess the prognostic value of pretreatment PET/computed tomography (CT) scans in colorectal cancer (CRC) patients with unresectable metastasis.

    Materials and methods: We retrospectively reviewed the pretreatment PET/CT images of 82 CRC patients with unresectable metastasis and their medical records. On PET/CT images, maximum standardized uptake value (SUVmax) of primary tumor, highest SUVmax of metastatic tumors and number of metastatic organs were identified. The patients were further divided into single and multiple organ metastases groups according to the extent of disease. Survival analysis was performed with the clinical variables and metabolic parameters from PET/CT.

    Results: In a total of 82 patients, the age of patients, highest SUVmax of metastatic tumors and number of metastatic organs were independent prognostic factors for overall survival (OS) (all P < 0.05), whereas the SUVmax of primary tumor was not. On multivariate analysis, only the SUVmax of metastatic tumor was a significant prognostic factor in the single organ metastasis group (P = 0.047), whereas the age and highest SUVmax of metastatic tumors were independent prognostic factors in the multiple organ metastases group (all P < 0.05).

    Conclusion: The highest SUVmax of metastatic tumors was an independent prognostic factor for OS in CRC patients with unresectable metastasis.

     

     

    Affiliations

    Eun Kyoung Choi  1 , Jin Kyoung Oh  1 , Ye Young Seo  2 , Jooyeon Jamie Im  1 , Yong-An Chung  1
    1 Department of Radiology, Incheon St.Mary's Hospital, College of Medicine, The Catholic University of Korea.
    2 Department of Nuclear Medicine, Inje University Sanggye Paik Hospital, Seoul, Republic of Korea.

  • 덧글달기
    덧글달기
       IP : 3.145.119.199

    등록